历代成方制剂及现代临床处方中细辛用量的调查与分析

张志国1; 谈发金2; 曹臣1; 邓桂明1

您当前的位置：

首页 >

文章列表页 >

历代成方制剂及现代临床处方中细辛用量的调查与分析

更新时间：2024-01-04

- 历代成方制剂及现代临床处方中细辛用量的调查与分析
- The Investigation and Analysis on the Dosage of Herba Asari in the Historical Preparations and the Present Clinical Prescriptions
- 中国实验方剂学杂志 2003年9卷第6期页码：55-57
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号：
- 纸质出版日期：2003
- 稿件说明：
移动端阅览
张志国1, 谈发金2, 曹臣1, 等. 历代成方制剂及现代临床处方中细辛用量的调查与分析[J]. 中国实验方剂学杂志, 2003,9(6):55-57.

ZHANG Zhi-guo1, TAN Fa-jin2, CAO Chen1, et al. The Investigation and Analysis on the Dosage of Herba Asari in the Historical Preparations and the Present Clinical Prescriptions[J]. Chinese journal of experimental traditional medical formulae, 2003, 9(6): 55-57.
张志国1, 谈发金2, 曹臣1, 等. 历代成方制剂及现代临床处方中细辛用量的调查与分析[J]. 中国实验方剂学杂志, 2003,9(6):55-57. DOI：

ZHANG Zhi-guo1, TAN Fa-jin2, CAO Chen1, et al. The Investigation and Analysis on the Dosage of Herba Asari in the Historical Preparations and the Present Clinical Prescriptions[J]. Chinese journal of experimental traditional medical formulae, 2003, 9(6): 55-57. DOI：

摘要

目的:了解历代成方制剂及现代临床处方中细辛的用量。方法:调查了《方剂学》、现行《药典》中的成方、临床中药汤剂含有细辛的处方。结果:古、近代多数处方中细辛的用量是现行《药典》上限用量的6倍～14倍;临床汤剂处方在《药典》范围内的占47.5%。结论:古、近代、现代临床处方中细辛用量与现行《药典》规定的用量相距甚远。

Abstract

OBJECTIVE: To comprehend the dosage of Herba Asari in the historical preparations and the present clinical prescriptions. METHODS:To investigate the prescriptions of TCM

The present pharmacopoeia and the clinical decoction prescriptions which comprise Herba Asari. RESULTS:The dosage of Herba Asari in ancient and modern times prescriptions is as six to fourteen times as the maximum of the present pharmacopoeia. It comprises 47.5% that the clinical prescriptions which dosage is in the scope of pharmacopoeia. CONCLUSION: The dosage of Herba Asari in ancient

modern and present times prescriptions is far away from the regulation dosage of pharmacopoeia.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

细辛、威灵仙联合应用止痛疗效观察